JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M400655200 on March 24, 2004

J. Biol. Chem., Vol. 279, Issue 25, 26013-26018, June 18, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/25/26013    most recent
M400655200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Crescenzo, G.
Right arrow Articles by O'Connor-McCourt, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Crescenzo, G.
Right arrow Articles by O'Connor-McCourt, M. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enhancement of the Antagonistic Potency of Transforming Growth Factor-{beta} Receptor Extracellular Domains by Coiled Coil-induced Homo- and Heterodimerization*

Gregory De Crescenzo{ddagger}, Phuong L. Pham§, Yves Durocher§, Heman Chao¶, and Maureen D. O'Connor-McCourt{ddagger}||

From the {ddagger}Cell Signaling and Proteomic Group, Health Sector, and §Bioprocess Platform, Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec H4P 2R2, and Helix BioPharma Corporation, Aurora, Ontario L4G 6X7, Canada

Transforming growth factor-{beta} (TGF-{beta}) plays a causal role in several human pathologies including fibrotic diseases and metastasis. TGF-{beta} signaling is mediated through its interaction with three types of cell surface receptors, RI, RII, and RIII. The soluble ectodomains of RII and RIII bind to TGF-{beta}, making them attractive candidates to sequester TGF-{beta} and inhibit its activity. To optimize the activity of the ectodomains, we studied the effect of artificially dimerizing them upon their kinetics of binding to TGF-{beta} using an optical biosensor and studied their antagonistic potencies using an in vitro signaling assay. We fused the RII ectodomain and the membrane-proximal ligand-binding domain of the RIII ectodomain to de novo designed heterodimerizing coil strands and demonstrated that the coil strands within the fusion proteins were capable of promoting the dimerization of the coil-tagged ectodomains. Our results indicate that coiled coil-induced dimerization of the ectodomains stabilized their interaction with TGF-{beta} as compared with the monomeric ectodomains. Also, in contrast to the monomeric ectodomains, which did not block signaling, the coiled coil-induced dimers were characterized by antagonistic potencies in the low nanomolar range.


Received for publication, January 20, 2004 , and in revised form, March 16, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Cell Signaling and Proteomic Group, Health Sector, Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Ave., Montreal, Quebec H4P 2R2, Canada. Tel.: 514-496-6382; Fax: 514-496-5143; E-mail: maureen.o'connor{at}nrc.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
E. V. Verona, Y. Tang, T. K. Millstead, A. P. Hinck, J. K. Agyin, and L.-Z. Sun
Expression, purification and characterization of BGERII: a novel pan-TGF{beta} inhibitor
Protein Eng. Des. Sel., July 1, 2008; 21(7): 463 - 473.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S J. Lin, T. F Lerch, R. W Cook, T. S Jardetzky, and T. K Woodruff
The structural basis of TGF-{beta}, bone morphogenetic protein, and activin ligand binding.
Reproduction, August 1, 2006; 132(2): 179 - 190.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. del Re, Y. Sidis, D. A. Fabrizio, H. Y. Lin, and A. Schneyer
Reconstitution and Analysis of Soluble Inhibin and Activin Receptor Complexes in a Cell-free System
J. Biol. Chem., December 17, 2004; 279(51): 53126 - 53135.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.